Paul S. Meltzer, MD, PhD
Head, Molecular Genetics Section
National Cancer Institute
Paul S. Meltzer, M.D., Ph.D., has been chief of genetic branch, Center for Cancer Research, National Cancer Institute since 2006. He leads the Molecular Genetics Group. The goal of the Molecular Genetics Section is to characterize the disturbances of genome function responsible for cancer development and to utilize this information to identify genes and pathways responsible for tumor development. The central importance of somatically acquired genetic and epigenetic alterations in the tumor genome is now well established. His work uses genome technologies to attack these problems in the context of specific diseases. Dr. Meltzer received his A.B in biology from Dartmouth College in 1967. He received his Ph.D. in biochemistry/developmental biology in 1972 from California Institute of Technology, and his M.D. from the University of Tennessee in 1980. He was a postdoctoral fellow in the Department of Genetics at the University of Cambridge from 1972-1974. This was followed by a residency in pediatrics at the Arizona Health Sciences Center in Tucson, Arizona, from July 1983-1985. He was a fellow in pediatric hematology-oncology at the Arizona Health Sciences Center, in Tucson, Arizona, from 1983-1985. Before his current position, Dr. Meltzer was a research assistant professor of pediatrics at the Arizona Health Sciences Center from July 1985- June, 1987. He was assistant professor of pediatrics at the University of Arizona, July 1987 –July 1990. He then became assistant professor of pediatrics and radiation oncology at the University of Michigan from August 1990-1993. In 1993, he was associate professor of pediatrics and radiation oncology at the University of Michigan. In 1993, he became the chief of the molecular genetics section, Cancer Genetics Branch, National Human Genome Research Institute at National Institutes of Health and he served in that capacity until 2006, when he became chief of genetics branch, Center for Cancer Research, National Cancer Institute.